Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · IEX Real-Time Price · USD
0.590
0.00 (0.02%)
Jul 22, 2024, 10:00 AM EDT - Market open
Forte Biosciences Employees
Forte Biosciences had 9 employees as of December 31, 2023. The number of employees increased by 3 or 50.00% compared to the previous year.
Employees
9
Change (1Y)
3
Growth (1Y)
50.00%
Revenue / Employee
n/a
Profits / Employee
-$3,571,444
Market Cap
21.87M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 9 | 3 | 50.00% |
| Dec 31, 2022 | 6 | 1 | 20.00% |
| Dec 31, 2021 | 5 | -4 | -44.44% |
| Dec 31, 2020 | 9 | 8 | 800.00% |
| Dec 31, 2019 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Cosmos Health | 102 |
| Cumberland Pharmaceuticals | 91 |
| Jaguar Health | 49 |
| Viracta Therapeutics | 40 |
| Gain Therapeutics | 32 |
| AIM ImmunoTech | 28 |
| OneMedNet | 20 |
| Aprea Therapeutics | 7 |
FBRX News
- 2 months ago - Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules - Business Wire
- 2 months ago - Forte Biosciences, Inc. Announces First Quarter 2024 Results and Provides Business Update - Business Wire
- 4 months ago - Forte Biosciences, Inc. Announces 2023 Results and Provides Business Update - Business Wire
- 8 months ago - Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules - Business Wire
- 8 months ago - Forte Biosciences, Inc. Announces Third Quarter 2023 Results and Provides Business Update - Business Wire
- 11 months ago - ISS and Glass Lewis Recommend Forte Biosciences Stockholders Vote FOR Boardroom Change at the Company's Upcoming Annual Meeting - Business Wire
- 11 months ago - Concerned Stockholders of Forte Biosciences and Its Independent Director Candidates Share Key Facts that Reinforce the Need for Urgent Change in the Company's Boardroom - Business Wire
- 11 months ago - Concerned Stockholders of Forte Biosciences File Definitive Proxy Statement and Send Letter to Stockholders - Business Wire